Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-46,200
Closed -$1.14M – 712
2024
Q2
$1.14M Buy
46,200
+12,041
+35% +$342K 0.11% 308
2024
Q1
$1.12M Buy
34,159
+212
+0.6% +$7.22K 0.11% 308
2023
Q4
$1.23M Buy
33,947
+27,495
+426% +$944K 0.14% 252
2023
Q3
$237K Buy
+6,452
New +$257K 0.03% 501
2022
Q4
– Sell
-23,969
Closed -$665K – 613
2022
Q3
$665K Sell
23,969
-41,072
-63% -$1.33M 0.1% 348
2022
Q2
$1.93M Buy
+65,041
New +$2.19M 0.17% 181
2021
Q3
– Sell
-106,613
Closed -$4.82M – 752
2021
Q2
$4.82M Buy
+106,613
New +$4.99M 0.32% 87

Other funds holding ADNT

PDT Partners's ADNT Position: Q3 2024 in Review

PDT Partners sold out of Adient (ADNT) in Q3 2024, closing a stake of 46,200 shares — an estimated $1.14M sold.

PDT Partners first reported a position in ADNT in Q2 2021 and held it in 7 quarters. The position peaked at $4.82M in Q2 2021. 261 funds tracked by Wall St. Rank hold ADNT as of Q3 2024.

  • PDT Partners reported no remaining Adient position as of Q3 2024 after selling out during the quarter.
  • PDT Partners sold 46,200 Adient shares in Q3 2024, an estimated $1.14M.
  • PDT Partners first reported a position in Adient in Q2 2021 and held it in 7 quarters.
  • PDT Partners's Adient position peaked at $4.82M in Q2 2021.
  • 261 funds tracked by Wall St. Rank held Adient as of Q3 2024.

Based on PDT Partners's 13F filing for Q3 2024, filed 14 Nov 2024.